209 related articles for article (PubMed ID: 24400993)
1. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
Diamond JM; Kawut SM; Lederer DJ; Ahya VN; Kohl B; Sonett J; Palmer SM; Crespo M; Wille K; Lama VN; Shah PD; Orens J; Bhorade S; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
Am J Transplant; 2011 Mar; 11(3):561-7. PubMed ID: 21299834
[TBL] [Abstract][Full Text] [Related]
3. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant dyslipidaemia influences primary graft dysfunction after lung transplantation.
Cottini SR; Ehlers UE; Pagnamenta A; Brandi G; Weder W; Schuepbach RA; Béchir M; Benden C
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):402-5. PubMed ID: 26718318
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.
Diamond JM; Lederer DJ; Kawut SM; Lee J; Ahya VN; Bellamy S; Palmer SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Kohl BA; Deutschman CC; Arcasoy S; Shah AS; Belperio JA; Wilkes D; Reynolds JM; Ware LB; Christie JD;
Am J Transplant; 2011 Nov; 11(11):2517-22. PubMed ID: 21883907
[TBL] [Abstract][Full Text] [Related]
6. Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.
Pottecher J; Roche AC; Dégot T; Helms O; Hentz JG; Schmitt JP; Falcoz PE; Santelmo N; Levy F; Collange O; Uring-Lambert B; Bahram S; Schaeffer M; Meyer N; Geny B; Lassalle P; Diemunsch P; Massard G; Kessler R; Steib A;
Transplantation; 2017 Jan; 101(1):112-121. PubMed ID: 27495752
[TBL] [Abstract][Full Text] [Related]
7. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
Shah RJ; Diamond JM; Lederer DJ; Arcasoy SM; Cantu EM; Demissie EJ; Kawut SM; Kohl B; Lee JC; Sonett J; Christie JD; Ware LB
Transl Res; 2012 Dec; 160(6):435-42. PubMed ID: 22989614
[TBL] [Abstract][Full Text] [Related]
8. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
[TBL] [Abstract][Full Text] [Related]
9. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD; Orens JB; Bhorade S; Crespo M; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
Chest; 2011 Aug; 140(2):489-496. PubMed ID: 21349925
[TBL] [Abstract][Full Text] [Related]
10. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.
Christie JD; Shah CV; Kawut SM; Mangalmurti N; Lederer DJ; Sonett JR; Ahya VN; Palmer SM; Wille K; Lama V; Shah PD; Shah A; Weinacker A; Deutschman CS; Kohl BA; Demissie E; Bellamy S; Ware LB;
Am J Respir Crit Care Med; 2009 Nov; 180(10):1010-5. PubMed ID: 19661249
[TBL] [Abstract][Full Text] [Related]
12. Primary Graft Dysfunction and Mortality Following Lung Transplantation: A Role for Proadrenomedullin Plasma Levels.
Riera J; Senna A; Cubero M; Roman A; Rello J;
Am J Transplant; 2016 Feb; 16(2):634-9. PubMed ID: 26461449
[TBL] [Abstract][Full Text] [Related]
13. Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation.
Kawut SM; Okun J; Shimbo D; Lederer DJ; De Andrade J; Lama V; Shah A; Milstone A; Ware LB; Weinacker A; Demissie E; Christie JD;
Chest; 2009 Jul; 136(1):237-244. PubMed ID: 19255296
[TBL] [Abstract][Full Text] [Related]
14. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
[TBL] [Abstract][Full Text] [Related]
15. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
16. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
17. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation.
Hoffman SA; Wang L; Shah CV; Ahya VN; Pochettino A; Olthoff K; Shaked A; Wille K; Lama VN; Milstone A; Ware LB; Orens J; Weinacker A; Demissie E; Bellamy S; Kawut SM; Hancock WW; Christie JD;
Am J Transplant; 2009 Feb; 9(2):389-96. PubMed ID: 19120076
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation.
Diamond JM; Porteous MK; Cantu E; Meyer NJ; Shah RJ; Lederer DJ; Kawut SM; Lee J; Bellamy SL; Palmer SM; Lama VN; Bhorade SM; Crespo M; Demissie E; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Arcasoy S; Wilkes DS; Ware LB; Christie JD;
PLoS One; 2012; 7(12):e51932. PubMed ID: 23284823
[TBL] [Abstract][Full Text] [Related]
19. Construct validity of the definition of primary graft dysfunction after lung transplantation.
Christie JD; Bellamy S; Ware LB; Lederer D; Hadjiliadis D; Lee J; Robinson N; Localio AR; Wille K; Lama V; Palmer S; Orens J; Weinacker A; Crespo M; Demissie E; Kimmel SE; Kawut SM
J Heart Lung Transplant; 2010 Nov; 29(11):1231-9. PubMed ID: 20655249
[TBL] [Abstract][Full Text] [Related]
20. Elevated pre-transplant left ventricular end-diastolic pressure increases primary graft dysfunction risk in double lung transplant recipients.
Li D; Weinkauf J; Hirji A; Kapasi A; Lien D; Nagendran J; Kim D; Ezekowitz J; Halloran K
J Heart Lung Transplant; 2019 Jul; 38(7):710-718. PubMed ID: 30850154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
